USPTO serial 79342587
EVAXION
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Aug 29, 2023
- Examiner
- DUENAS, TAYLOR S
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with EVAXION?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michael R. Rizzo
Michael R. Rizzo Saunders & Silverstein LLP14 Cedar Street, Suite 224Amesbury, MA 01913United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceuticals and medical preparations for treating cancer and infectious diseases; medicine for treatment of cancer; pharmaceuticals preparations and substances for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; biopharmaceuticals for the treatment of cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis, and parasites; immunotherapy preparations for treating cancer and infectious diseases; monoclonal antibodies (mAb) for medical purposes; vaccines for human use; viral vaccines; vaccine adjuvants; cells for medical use | ACTIVE | — |
| 009 | Downloadable software for design of pharmaceuticals; downloadable artificial intelligence software for design of pharmaceuticals; downloadable artificial intelligence and machine learning software for design of pharmaceuticals; downloadable artificial intelligence software platforms for design of pharmaceuticals; downloadable software for evaluating medical treatment options and treatment outcomes for cancer; downloadable software for design and development of immunotherapy; downloadable software and downloadable artificial intelligence software for identifying antigens and epitopes; downloadable software and downloadable artificial intelligence software for designing and developing vaccines and medicines; downloadable software and downloadable artificial intelligence software for designing pharmaceuticals for cancer, viral diseases, allergy, autoimmune diseases, microbiota dysbiosis and parasites | ACTIVE | — |
| 042 | Scientific and technological research services in the field of oncology, infectious diseases, and immunology; scientific research and development services in the fields of immunology and oncology; decoding of data; research and development of pharmaceuticals; medical and pharmacological research services; clinical medical research in the field of oncology, infectious diseases, and immunology; research and development of vaccines and medicines; scientific and technological research relating to virus, oncology, and autoimmune diseases; scientific and technological research relating to allergies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by EVAXION BIOTECH A/S
- Other trademarks owned by EVAXION BIOTECH A/S
- Other trademarks owned by EVAXION BIOTECH A/S
- Other trademarks owned by Evaxion A/S
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 042
- Similar marks named EVAXION
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Feb 19, 2026 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Apr 24, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 1, 2024 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Feb 1, 2024 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Feb 1, 2024 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 1, 2024 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 26, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Dec 4, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Dec 4, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Nov 29, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Aug 29, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Aug 29, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jun 13, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jun 13, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 13, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 24, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| May 24, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| May 24, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| May 10, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 10, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| May 4, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 3, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 3, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 21, 2023 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 27, 2023 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 27, 2023 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 30, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 29, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 26, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 18, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 21, 2022 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jun 17, 2022 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 16, 2022 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |